SCHEMBL571708

SCHEMBL571708

COc1c(-c2ccc(O)cc2)oc2c(C)c(O)c(C)c(O)c2c1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.57
ABCG2 Q9UNQ0 1/20 0.57
KDM4E B2RXH2 4/20 0.56
CYP3A4 P08684 2/20 0.56
CYP2D6 P10635 2/20 0.56
POLB P06746 2/20 0.56
APEX1 P27695 2/20 0.56
RECQL P46063 2/20 0.56
POLH Q9Y253 2/20 0.56
MCL1 Q07820 1/20 0.56
ESR1 P03372 1/20 0.53
ESR2 Q92731 1/20 0.53
MAPT P10636 4/20 0.53
GAA P10253 3/20 0.53
TUBB4A P04350 2/20 0.52
TUBB P07437 2/20 0.52
TUBA3C P0DPH7 2/20 0.52
TUBA1B P68363 2/20 0.52
TUBA4A P68366 2/20 0.52
TUBB4B P68371 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31324031 0.86 ABCB1 (0.63) ABCB1ABCG2KDM4ECYP3A4CYP2D6
SCHEMBL30319762 0.85 ESR1 (0.59) ABCB1ABCG2KDM4ECYP3A4CYP2D6
Calycopterin SCHEMBL2214965 0.84 KDM4E (0.73) ABCB1ABCG2KDM4ECYP3A4CYP2D6
SCHEMBL4135376 0.81 ABCB1 (0.67) ABCB1ABCG2KDM4ECYP3A4CYP2D6
SCHEMBL29782768 0.80 ABCB1 (0.72) ABCB1ABCG2KDM4ECYP3A4CYP2D6
SCHEMBL29782758 0.80 ABCB1 (0.72) ABCB1ABCG2KDM4ECYP3A4CYP2D6
SCHEMBL12436894 0.79 ABCB1 (0.54) ABCB1ABCG2KDM4ECYP3A4CYP2D6
SCHEMBL31080767 0.78 KDM4E (0.67) ABCB1ABCG2KDM4ECYP3A4CYP2D6
SCHEMBL31238141 0.77 KDM4E (0.68) ABCB1ABCG2KDM4ECYP3A4CYP2D6
SCHEMBL22361649 0.77 MAPT (0.65) ABCB1ABCG2KDM4ECYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2014-08-21 US disclosed
US-8748177-B2 Compositions for proliferation of cells and related methods THE HOSPITAL FOR SICK CHILDREN (CA) 2014-06-10 US disclosed
EP-2598150-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS The Hospital For Sick Children (CA) 2013-06-05 EP disclosed
WO-2012018643-A2 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2012-02-09 WO disclosed
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2011-12-08 US disclosed
WO-2010039679-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS THE HOSPITAL FOR SICK CHILDREN (CA) 2010-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140234271-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 ABCB1 3036/4885ABCG2 2253/4885KDM4E 674/4885
US-20110301105-A1 COMPOSITIONS FOR PROLIFERATION OF CELLS AND RELATED METHODS MKI67, KRT18, PROX1 ABCB1 3036/4885ABCG2 2253/4885KDM4E 674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.